In an effort to illustrate that genomic surveillance can build the foundation for scaleable precision phage therapy, an international collaboration analyzed the genomes of over 15,000 cases of ...
SAN JOSE, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the completion of a therapy training initiative supporting clinicians ...
A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of ...
In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (OTC:NUMIF) has taken steps to get out in front of the curve. Today, ...
The FDA has accepted a New Drug Application filed by Lykos Therapeutics for MDMA-assisted therapy for PTSD The application was supported by clinical trial data collected over two decades of research ...
Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service members. First-of-its-kind therapist preparation supports the Department ...
If approved for medical use, the Drug Enforcement Administration would be required to reschedule the drug. MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results